Showing results (211-220 of 257) with videos related to
Sort By:
Pageof 26
The Lancet. Respiratory Medicine|September 10, 2022
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialAlexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, et al.Resuscitation Plus|June 14, 2024
Health-related quality of life one year after refractory cardiac arrest treated with conventional or extracorporeal CPR; a secondary analysis of the INCEPTION-trialAnina F van de Koolwijk, Thijs S R Delnoij, Martje M Suverein, et al.Lancet (London, England)|July 7, 2026
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trialOlivier van Minnen, Annemieke Oude Lansink-Hartgring, Rombout B E van Amstel, et al.Iscience|September 6, 2023
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Tamas Pongracz, Tonći Šuštić, et al.Blood Advances|July 24, 2025
Post-transfusion recovery, quality and metabolism of short and long-term stored platelets during controlled inflammationStefan F van Wonderen, Floor L F van Baarle, Philippa G Phelp, et al.Resuscitation Plus|February 16, 2026
Attitudes of patients and family members towards deferred and waived consent in ECPR research, an ancillary study of the INCEPTION trialStijn E D M Eussen, Anina F van de Koolwijk, Thijs S R Delnoij, et al.American Heart Journal|February 10, 2019
Early initiation of extracorporeal life support in refractory out-of-hospital cardiac arrest: Design and rationale of the INCEPTION trialMartine E Bol, Martje M Suverein, Roberto Lorusso, et al.The New England Journal of Medicine|May 24, 2023
Platelet Transfusion before CVC Placement in Patients with ThrombocytopeniaFloor L F van Baarle, Emma K van de Weerdt, Walter J F M van der Velden, et al.Trials|May 16, 2022
Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trialOlivier van Minnen, Annemieke Oude Lansink-Hartgring, Bas van den Boogaard, et al.European Heart Journal. Acute Cardiovascular Care|April 16, 2026
Cost-effectiveness of extracorporeal CPR for out-of-hospital cardiac arrest: a trial-based Markov-model with a lifetime horizonAnina F van de Koolwijk, Andrea Gabrio, Thijs S R Delnoij, et al.Pageof 26